A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial. (2019)
Attributed to:
MICA: A comprehensive genomic and functional approach to discover new ion channel targets for human pain treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.40766
Publication URI: https://www.repository.cam.ac.uk/handle/1810/293654
Type: Journal Article/Review